113 related articles for article (PubMed ID: 24729612)
1. B7h triggering inhibits the migration of tumor cell lines.
Dianzani C; Minelli R; Gigliotti CL; Occhipinti S; Giovarelli M; Conti L; Boggio E; Shivakumar Y; Baldanzi G; Malacarne V; Orilieri E; Cappellano G; Fantozzi R; Sblattero D; Yagi J; Rojo JM; Chiocchetti A; Dianzani U
J Immunol; 2014 May; 192(10):4921-31. PubMed ID: 24729612
[TBL] [Abstract][Full Text] [Related]
2. Triggering of B7h by the ICOS modulates maturation and migration of monocyte-derived dendritic cells.
Occhipinti S; Dianzani C; Chiocchetti A; Boggio E; Clemente N; Gigliotti CL; Soluri MF; Minelli R; Fantozzi R; Yagi J; Rojo JM; Sblattero D; Giovarelli M; Dianzani U
J Immunol; 2013 Feb; 190(3):1125-34. PubMed ID: 23275603
[TBL] [Abstract][Full Text] [Related]
3. B7h triggering inhibits umbilical vascular endothelial cell adhesiveness to tumor cell lines and polymorphonuclear cells.
Dianzani C; Minelli R; Mesturini R; Chiocchetti A; Barrera G; Boscolo S; Sarasso C; Gigliotti CL; Sblattero D; Yagi J; Rojo JM; Fantozzi R; Dianzani U
J Immunol; 2010 Oct; 185(7):3970-9. PubMed ID: 20817864
[TBL] [Abstract][Full Text] [Related]
4. ICOS-Ligand Triggering Impairs Osteoclast Differentiation and Function In Vitro and In Vivo.
Gigliotti CL; Boggio E; Clemente N; Shivakumar Y; Toth E; Sblattero D; D'Amelio P; Isaia GC; Dianzani C; Yagi J; Rojo JM; Chiocchetti A; Boldorini R; Bosetti M; Dianzani U
J Immunol; 2016 Nov; 197(10):3905-3916. PubMed ID: 27798154
[TBL] [Abstract][Full Text] [Related]
5. Differential induction of IL-17, IL-10, and IL-9 in human T helper cells by B7h and B7.1.
Mesturini R; Gigliotti CL; Orilieri E; Cappellano G; Soluri MF; Boggio E; Woldetsadik A; Dianzani C; Sblattero D; Chiocchetti A; Yagi J; Rojo JM; Dianzani U
Cytokine; 2013 Oct; 64(1):322-30. PubMed ID: 23778031
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of T-cell expansion caused by inducible costimulator/B7h costimulation blockade in direct allorecognition pathway.
Du JF; Li QY; Ji XQ; Chen G; Bai X; Zuo FY; Yu B
Transplant Proc; 2011 Dec; 43(10):3960-3. PubMed ID: 22172879
[TBL] [Abstract][Full Text] [Related]
7. ICOSL Stimulation by ICOS-Fc Accelerates Cutaneous Wound Healing In Vivo.
Stoppa I; Gigliotti CL; Clemente N; Pantham D; Dianzani C; Monge C; Puricelli C; Rolla R; Sutti S; Renò F; Boldorini R; Boggio E; Dianzani U
Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806368
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis of peripheral T cells in rodent cardiac allograft recipients induced by donor-specific transfusion with impaired inducible costimulator/B7 homologous protein allorecognition.
Du JF; Shen XF; Ji XQ; Chen G; Bai X; Zuo FY; Yu B
Transplant Proc; 2013 Mar; 45(2):564-8. PubMed ID: 23498793
[TBL] [Abstract][Full Text] [Related]
9. B7h-expressing dendritic cells and plasma B cells mediate distinct outcomes of ICOS costimulation in T cell-dependent antibody responses.
Larimore K; Liang L; Bakkour S; Sha WC
BMC Immunol; 2012 Jun; 13():29. PubMed ID: 22686515
[TBL] [Abstract][Full Text] [Related]
10. B7h is required for T cell activation, differentiation, and effector function.
Nurieva RI; Mai XM; Forbush K; Bevan MJ; Dong C
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14163-8. PubMed ID: 14615582
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy of experimental melanoma with ICOS-Fc loaded in biocompatible and biodegradable nanoparticles.
Clemente N; Boggio E; Gigliotti LC; Raineri D; Ferrara B; Miglio G; Argenziano M; Chiocchetti A; Cappellano G; Trotta F; Caldera F; Capucchio MT; Yagi J; Rojo MJ; Renò F; Cavalli R; Dianzani C; Dianzani U
J Control Release; 2020 Apr; 320():112-124. PubMed ID: 31962094
[TBL] [Abstract][Full Text] [Related]
12. ICOS-Fc as innovative immunomodulatory approach to counteract inflammation and organ injury in sepsis.
Alves GF; Stoppa I; Aimaretti E; Monge C; Mastrocola R; Porchietto E; Einaudi G; Collotta D; Bertocchi I; Boggio E; Gigliotti CL; Clemente N; Aragno M; Fernandes D; Cifani C; Thiemermann C; Dianzani C; Dianzani U; Collino M
Front Immunol; 2022; 13():992614. PubMed ID: 36119089
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of CD8+ T cell responses by ICOS/B7h costimulation.
Wallin JJ; Liang L; Bakardjiev A; Sha WC
J Immunol; 2001 Jul; 167(1):132-9. PubMed ID: 11418641
[TBL] [Abstract][Full Text] [Related]
14. ICOS-induced B7h shedding on B cells is inhibited by TLR7/8 and TLR9.
Logue EC; Bakkour S; Murphy MM; Nolla H; Sha WC
J Immunol; 2006 Aug; 177(4):2356-64. PubMed ID: 16887997
[TBL] [Abstract][Full Text] [Related]
15. ICOS/ICOSL upregulation mediates inflammatory response and endothelial dysfunction in type 2 diabetes mellitus.
Zhang HY; Ruan LB; Li Y; Yang TR; Liu WJ; Jiang YX; Li TR; Quan J; Xuan W
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8898-8908. PubMed ID: 30575933
[TBL] [Abstract][Full Text] [Related]
16. [Blocking ICOS-B7h signal pathway by ICOS-Ig fusion protein inhibits function of allogeneic T lymphocytes].
Bao XC; Wang JM; Shen Q; Zhou H; Yang JM; Song NX; Wang B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):913-7. PubMed ID: 19698228
[TBL] [Abstract][Full Text] [Related]
17. Role of the ICOS-B7h costimulatory pathway in the pathophysiology of chronic allograft rejection.
Kashizuka H; Sho M; Nomi T; Ikeda N; Kuzumoto Y; Akashi S; Tsurui Y; Mizuno T; Kanehiro H; Yagita H; Nakajima Y; Sayegh MH
Transplantation; 2005 May; 79(9):1045-50. PubMed ID: 15880041
[TBL] [Abstract][Full Text] [Related]
18. ICOS:ICOS-ligand interaction is required for type 2 innate lymphoid cell function, homeostasis, and induction of airway hyperreactivity.
Maazi H; Patel N; Sankaranarayanan I; Suzuki Y; Rigas D; Soroosh P; Freeman GJ; Sharpe AH; Akbari O
Immunity; 2015 Mar; 42(3):538-51. PubMed ID: 25769613
[TBL] [Abstract][Full Text] [Related]
19. ICOS-ligand expression on plasmacytoid dendritic cells supports breast cancer progression by promoting the accumulation of immunosuppressive CD4+ T cells.
Faget J; Bendriss-Vermare N; Gobert M; Durand I; Olive D; Biota C; Bachelot T; Treilleux I; Goddard-Leon S; Lavergne E; Chabaud S; Blay JY; Caux C; Ménétrier-Caux C
Cancer Res; 2012 Dec; 72(23):6130-41. PubMed ID: 23026134
[TBL] [Abstract][Full Text] [Related]
20. B7h (ICOS-L) maintains tolerance at the fetomaternal interface.
Riella LV; Dada S; Chabtini L; Smith B; Huang L; Dakle P; Mfarrej B; D'Addio F; Adams LT; Kochupurakkal N; Vergani A; Fiorina P; Mellor AL; Sharpe AH; Yagita H; Guleria I
Am J Pathol; 2013 Jun; 182(6):2204-13. PubMed ID: 23578385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
